High-altitude cerebral effects: risks and mechanisms

The Lancet Neurology

Volumn 8, Issue 7, 2009, Pages 604-605

  Burtscher, Martin ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE INHIBITOR;

ALTITUDE; ALTITUDE DISEASE; BRAIN EDEMA; BRAIN HYPOXIA; BRAIN PERFUSION; DISEASE COURSE; HUMAN; LETTER; METABOLIC SYNDROME X; MOUNTAINEERING; NEUROLOGIC DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; BIOSYNTHESIS; HEADACHE; NOTE; PATHOPHYSIOLOGY;

ALTITUDE SICKNESS; BRAIN EDEMA; CYCLOOXYGENASE INHIBITORS; HEADACHE; HYPOXIA, BRAIN; PROSTAGLANDINS;

EID: 67649388067     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(09)70160-7     Document Type: Letter

References (4)

1. Wilson M.H., Newman S., and Imray C.H. The cerebral effects of ascent to high altitudes. Lancet Neurol 8 (2009) 175-191
2. Burtscher M., Likar R., Nachbauer W., and Philadelphy M. Aspirin for prophylaxis against headache at high altitudes: randomised, double blind, placebo controlled trial. BMJ 316 (1998) 1057-1058
3. Ray C.J., Abbas M.R., Coney A.M., and Marshall J.M. Interactions of adenosine, prostaglandins and nitric oxide in hypoxia-induced vasodilation: in vivo and in vitro studies. J Physiol 544 (2002) 195-209
4. 2) induces headache in healthy subjects. Cephalalgia 29 (2009) 509-519